Oncolytics Biotech (ONCY) Stock Price, Quote, News & History | Benzinga

Oncolytics Biotech Inc (ONCY) Stock Price, Quote, News & History

ONCYNASDAQ

Trade with Public

Trade with Public

$0.8310

-0.0138-1.63%

At close: Aug 19, 5:00 PM EST

$0.8333

0.00230.28%

After Hours: 5:27 PM EST

Earnings: Q2 2026 Earnings were released on Wed Aug 12th, before the market open

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$0.84

Close

$0.83

Volume / Avg.

606.77K / 1.34M

Day Range

$0.83 - $0.86

52 Wk Range

0.73 - 1.51

Market Cap

$106.25M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

6.57%

Days to Cover

7.09

Recent Oncolytics Biotech Inc News

Penny Stock Oncolytics Biotech Says Colorecatal Cancer Drug's Durability Tops Historical Benchmarks

Oncolytics shares rise as pelareorep shows 19.5-month response durability and higher response rates in colorectal cancer study.

Vandana Singh

Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Partner Content

Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer

Partner Content

Pancreatic Cancer Could Overtake Colorectal Cancer To Become Second Leading Cause Of Cancer Death – Oncolytics Is Working On A Promising Treatment

Partner Content

Oncolytics Biotech (NASDAQ: ONCY) (TSX: ONC) Fights Cancer With Pelareorep, Which Has Received FDA Fast Track Designation For Breast And Pancreatic Cancer

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-26.70M

Investing Cash Flow (TTM)

-11.00K

Financing Cash Flow (TTM)

20.23M

Free Cash Flow (TTM)

-26.72M

Capital Expenditure (TTM)

-11.00K

Net Change in Cash (TTM)

-6.49M

Analyst Trends and Forecast

1

May

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$104.33M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-41.32%

Earnings Yield % (FWD)

-31.01%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.05

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$4.12M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.84

Close

$0.83

Volume / Avg.

606.77K / 1.34M

Day Range

$0.83 - $0.86

52 Wk Range

0.73 - 1.51

Market Cap

$106.25M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

6.57%

Days to Cover

7.09

About

Sector

Health Care

Industry

Biotechnology

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelar...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Oncolytics Biotech (ONCY) stock?

A

You can purchase shares of Oncolytics Biotech (NASDAQ:ONCY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Oncolytics Biotech (ONCY) competitors?

A

Other companies in Oncolytics Biotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Oncolytics Biotech (ONCY) stock?

A

Oncolytics Biotech has a consensus price target of $4.67.

Q

What is the current price for Oncolytics Biotech (ONCY)?

A

The stock price for Oncolytics Biotech (NASDAQ: ONCY) is $0.8333 last updated August 19, 2026 at 5:27 PM EDT.

Q

Does Oncolytics Biotech (ONCY) pay a dividend?

A

There are no upcoming dividends for Oncolytics Biotech.

Q

When is Oncolytics Biotech (NASDAQ:ONCY) reporting earnings?

A

Oncolytics Biotech does not have any upcoming earnings scheduled.

Q

Is Oncolytics Biotech (ONCY) going to split?

A

There is no upcoming split for Oncolytics Biotech.

Q

What sector and industry does Oncolytics Biotech (ONCY) operate in?

A

Oncolytics Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.